Revision: June 13, 2019, 1:36 p.m.
SB 224-FN - VERSION ADOPTED BY BOTH BODIES
SENATE BILL 224-FN
SPONSORS: Sen. Rosenwald, Dist 13; Sen. Fuller Clark, Dist 21; Sen. Hennessey, Dist 5; Sen. Chandley, Dist 11; Sen. Sherman, Dist 24; Rep. Nordgren, Graf. 12; Rep. Marsh, Carr. 8; Rep. Campion, Graf. 12; Rep. Cushing, Rock. 21; Rep. Berrien, Rock. 18
This bill clarifies insurance coverage for treatment for pediatric autoimmune neuropsychiatric disorders.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
8May2019... 1673h 19-1020
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Nineteen
Be it Enacted by the Senate and House of Representatives in General Court convened:
II. Notwithstanding any other provision of law, each insurer that issues or renews any policy of [group] accident or health insurance and each nonprofit health service corporation under RSA 420-A and health maintenance organization under RSA 420-B providing benefits for disease or sickness in the state of New Hampshire shall provide benefits for treatment and diagnosis of certain biologically-based mental illnesses under the same terms and conditions and which are no less extensive than coverage provided for any other type of health care for physical illness.
(f) Obsessive-compulsive disorder, including pediatric autoimmune neuropsychiatric disorders, when treatment, including the use of intravenous immunoglobulin therapy, is ordered by a physician.
(f) Obsessive-compulsive disorder, including pediatric autoimmune neuropsychiatric disorders.
I. Section 3 of this act shall take effect July 1, 2024.
II. The remainder of this act shall take effect 60 days after its passage.
SB 224-FN- FISCAL NOTE
AS AMENDED BY THE HOUSE (AMENDMENT #2019-1673h)
FISCAL IMPACT: [ X ] State [ ] County [ ] Local [ ] None
Estimated Increase / (Decrease)
[ X ] General [ ] Education [ X ] Highway [ X ] Other - Various Governmental Funds
This bill clarifies insurance coverage for treatment for pediatric autoimmune neuropsychiatric disorders. The Insurance Department assumes this clarification is consistent with obsessive-compulsive disorders and does not expand on the class of obsessive compulsive disorders. Therefore, the Department assumes there would be no impact on insurance claims, premiums or insurance premium tax revenue.
The Department of Administrative Services indicates the state health benefit plan for employees and retirees (the Plan) currently covers the illnesses outlined in RSA 417-E:1. Since the bill expands the treatment included in RSA 417-E:1, III, (f), if such treatment is ordered there will be a cost to the Plan. The Department is not able to determine if any members will utilize this treatment, therefore the impact on state expenditures is indeterminable.
The Department of Health and Human Services assumes that since children covered under the Medicaid program are eligible for the recommended treatments for pediatric autoimmune neuropsychiatric disorders, the bill would not result in additional costs to the Medicaid program.
Departments of Insurance, Administrative Services and Health and Human Services